Verastem, Inc. VSTM 深 沪
等待开盘 03-26 09:30:00 美东时间
5.025
+0.095
+1.93%
华盛通- 最 高5.22
- 今 开5.01
- 成交量 158.40万股
- 最 低 4.97
- 昨 收 4.93
- 总市值 4.41亿
- 52周最高 11.245
- 市盈率 静 --
- 换手率 1.80%
- 52周最低 4.01
- 委 比 54.63%
- 总股本 8783.51万
- 历史最高 225.84
- 量 比 0.72
- 振 幅 5.07%
- 历史最低 2.10
- 每 手 1
- 风险率 1.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅101%！甲骨文获花旗升目标价至320美元，维持"买入"评级
今日重点评级关注：Freedom Capital Markets：维持LifeMD"买入"评级，目标价从8美元升至10美元；Chardan Capital：维持Opus Genetics"买入"评级，目标价从9美元升至11美元
03-13 09:59
BTIG Assumes Verastem at Buy, Announces Price Target of $19
BTIG analyst Jeet Mukherjee assumes Verastem (NASDAQ:VSTM) with a Buy rating and announces Price Target of $19.
03-12 18:59
Earnings Summary: Verastem Q4
The Q4 earnings report for Verastem (NASDAQ:VSTM) was released on Wednesday, Ma...
03-05 05:07
Verastem Q4 Adj. EPS $(0.48) Beats $(0.53) Estimate, Sales $17.535M Beat $15.682M Estimate
Verastem (NASDAQ:VSTM) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.53) by 9.26 percent. This is a 20 percent increase over losses of $(0.60) per share from the same
03-05 05:02
Earnings Scheduled For March 4, 2026
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is estimated...
03-04 19:11
Earnings Outlook For Verastem
Verastem (NASDAQ:VSTM) is gearing up to announce its quarterly earnings on Wedn...
03-04 01:03
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
Verastem Oncology Expects $17.5M In Q4 2025 Revenues For AVMAPKI FAKZYNJA CO-PACK, Up From $12.5M In Q4 2024, While Advancing VS-7375 Development In 2026
Based on preliminary, unaudited results, Verastem expects AVMAPKI™ FAKZYNJA™ CO-PACK net product revenues of approximately $17.5 million for the fourth quarter of 2025 and approximately $30.9 million for
02-04 20:34
$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News Commentary VANCOUVER, BC, Jan. 30, 2026 /PRNewswire/ -- The global oncology sector is rocketing toward $668 billion in 2034[...
01-30 23:19
Verastem updates oncology strategy in new corporate presentation
An update from Verastem ( ($VSTM) ) is now available. On January 8, 2026, Veras...
01-09 05:51
